Different anti-TNF-α therapies have been studied in patients with documented atherosclerosis, although the clinical results were not entirely consistent [8,9,10] and further insights are warranted regarding the regulation of TNF-α in patients with SCAD. This evidence concerns the gene TNF and atherosclerosis.